Literature DB >> 34981489

The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review.

Hamed Baharara1, Ali Tafazoli Moghadam2, Amirhossein Sahebkar3,4,5,6, Seyed Ahmad Emami7,8, Tara Tayebi9, Amir Hooshang Mohammadpour10,11.   

Abstract

Hedera helix (ivy) belongs to the genus Hedera of the Araliaceae family. The leaf of this plant has several active ingredients with medicinal uses. The active constituents of H. helix include monodesmoside α-hederin, hederacoside B, hederacoside C, and hederacoside D.H. helix leave have been used for the treatment of cough and respiratory problems, and now, other uses have emerged. As a medicinal plant, H. helix has been approved by the German Commission E due to its antispasmodic, spasmolytic, antimicrobial, anti-inflammatory, anthelmintic, antioxidative, antitumor, and antileishmanial activities. It comes with several formulations, including tablets, liquids, and topical ointments. In this review, we focus on the respiratory effects of tablet and liquid forms of H. helix.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Araliaceae; Bronchitis; Cough; English ivy; Hedera helix; Respiratory problem

Mesh:

Substances:

Year:  2021        PMID: 34981489     DOI: 10.1007/978-3-030-73234-9_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme.

Authors:  Samuel Büechi; Roger Vögelin; Mónica Mennet von Eiff; Mac Ramos; Jörg Melzer
Journal:  Forsch Komplementarmed Klass Naturheilkd       Date:  2005-12-22

Review 2.  A Valuable Option for the Treatment of Respiratory Diseases: Review on the Clinical Evidence of the Ivy Leaves Dry Extract EA 575®.

Authors:  Christopher Lang; Patricia Röttger-Lüer; Christiane Staiger
Journal:  Planta Med       Date:  2015-04-15       Impact factor: 3.352

3.  Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trial.

Authors:  Bernd Kemmerich; Reinhild Eberhardt; Holger Stammer
Journal:  Arzneimittelforschung       Date:  2006

4.  A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575®) vs. placebo in the treatment of adults with acute cough.

Authors:  A Schaefer; M S Kehr; B M Giannetti; M Bulitta; C Staiger
Journal:  Pharmazie       Date:  2016-09-01       Impact factor: 1.267

5.  To evaluate the efficacy and safety of CofNovex plus (EMA) syrup.

Authors:  Zubair Ali; Muhammad Daniyal; Muhammad Khalid Adhia; Anees Alam; Babar Sarfaraz; Abdul Sattar; Khan Usmanghani
Journal:  Pak J Pharm Sci       Date:  2017-03       Impact factor: 0.684

6.  efficacy of dry extract of ivy leaves in the treatment of productive cough.

Authors:  Karina Schönknecht; Andrzej M Fal; Agnieszka Mastalerz-Migas; Monika Joachimiak; Zbigniew Doniec
Journal:  Wiad Lek       Date:  2017

7.  [Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves].

Authors:  Olav Marzian
Journal:  MMW Fortschr Med       Date:  2007-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.